Frontier Biotechnologies, Inc. (China)

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005XF5
CNY
19.20
8.8 (84.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
1,141.31
1,342.68
1,671.45
1,830.23
2,143.05
602.83
Shareholder's Funds
1,141.31
1,342.68
1,671.45
1,830.23
2,143.05
602.83
Minority Interest
0.00
0.00
0.00
25.59
-2.42
0.16
Long-Term Borrowings
406.56
380.18
278.17
292.55
32.49
39.99
Secured Loans
406.56
380.18
278.17
292.55
32.49
39.99
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
16.35
31.46
21.53
0.41
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
95.71
102.88
138.64
7.91
12.50
17.50
Current Liabilities
Trade Payables
6.78
17.44
24.99
19.08
13.55
3.98
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
395.20
380.16
277.23
399.49
112.71
82.44
Total Liabilities
1,812.14
2,140.13
2,410.86
2,532.63
2,516.29
939.53
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
445.87
829.20
758.53
653.74
341.03
167.30
Less: Accumulated Depreciation
42.06
29.78
20.63
11.43
16.39
12.17
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
403.81
799.42
737.89
642.31
324.64
155.13
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
29.96
0.00
0.00
20.06
30.07
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
4.40
7.81
6.94
31.19
20.87
4.63
Total Non-Current Assets
589.52
1,037.34
1,004.78
955.12
668.12
483.42
Current Assets Loans & Advances
Current Investments
652.23
415.06
700.12
679.36
939.58
184.31
Inventories
41.06
59.00
55.61
38.62
13.53
19.47
Sundry Debtors
34.75
63.01
36.14
22.34
31.87
12.77
Cash and Bank
248.98
526.66
550.89
800.85
839.09
227.39
Other Current Assets
1,209.15
1,079.31
1,361.53
1,565.76
1,835.57
444.76
Short Term Loans and Advances
232.13
15.57
18.77
24.58
11.50
0.81
Total Current Assets
1,222.62
1,102.79
1,406.08
1,577.51
1,848.17
456.11
Net Current Assets (Including Current Investments)
827.41
722.63
1,128.85
1,178.02
1,735.46
373.67
Total Current Assets Excluding Current Investments
1,222.62
1,102.79
1,406.08
1,577.51
1,848.17
456.11
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,812.14
2,140.13
2,410.86
2,532.63
2,516.29
939.53
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
406.56
380.18
278.17
292.55
32.49
39.99
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 11.12% vs -39.02% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -48.03% vs 46.12% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -49.49% vs 8.34% in Dec 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 10.87% vs -21.57% in Dec 2023

Compare Balance Sheet Results of Frontier Biotechnologies, Inc. (China)
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
1,141.31
0
1,141.31
0.00%
Shareholder's Funds
1,141.31
0
1,141.31
0.00%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
406.56
0
406.56
0.00%
Secured Loans
406.56
0
406.56
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
16.35
0
16.35
0.00%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
95.71
0
95.71
0.00%
Current Liabilities
Trade Payables
6.78
0
6.78
0.00%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
395.20
0
395.20
0.00%
Total Liabilities
1,812.14
0
1,812.14
0.00%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
445.87
0
445.87
0.00%
Less: Accumulated Depreciation
42.06
0
42.06
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
403.81
0
403.81
0.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
29.96
0
29.96
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
4.40
0
4.40
0.00%
Total Non-Current Assets
589.52
0
589.52
0.00%
Current Assets Loans & Advances
Current Investments
652.23
0
652.23
0.00%
Inventories
41.06
0
41.06
0.00%
Sundry Debtors
34.75
0
34.75
0.00%
Cash and Bank
248.98
0
248.98
0.00%
Other Current Assets
1,209.15
0
1,209.15
0.00%
Short Term Loans and Advances
232.13
0
232.13
0.00%
Total Current Assets
1,222.62
0
1,222.62
0.00%
Net Current Assets (Including Current Investments)
827.41
0
827.41
0.00%
Total Current Assets Excluding Current Investments
1,222.62
0
1,222.62
0.00%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
1,812.14
0
1,812.14
0.00%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
406.56
0
406.56
0.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 79.36 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.12% vs -39.02% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 16.35 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -48.03% vs 46.12% in Dec 2023

Annual - Fixed Assets
Fixed Assets 403.81 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -49.49% vs 8.34% in Dec 2023

Annual - Investments
Investments 29.96 Million
in Dec 2024

Figures in Million
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 1,222.62 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.87% vs -21.57% in Dec 2023